Kyle Armbruster

Title: The Innovative Contributions of Kyle Armbruster

Introduction

Kyle Armbruster is an accomplished inventor based in Douglassville, PA. He has made significant contributions to the field of pharmaceuticals, particularly through his work on squalamine dilactate. His innovative approach has led to advancements in therapeutic applications, showcasing his dedication to improving health outcomes.

Latest Patents

Armbruster holds a patent for "Polymorphic and amorphous salt forms of squalamine dilactate." This invention focuses on select squalamine salts, detailing methods of their synthesis and therapeutic uses. The patent emphasizes the advantages of these salts in terms of manufacturing, product stability, and toxicity. Specifically, it addresses various forms of the dilactate salt of squalamine and their effectiveness in inhibiting neovascularization and endothelial cell proliferation.

Career Highlights

Kyle Armbruster is currently associated with Ohr Pharmaceutical Inc., where he continues to drive innovation in the pharmaceutical industry. His work has not only contributed to the company's portfolio but has also positioned him as a key player in the development of new therapeutic solutions.

Collaborations

Armbruster collaborates with talented professionals such as Eric Chellquist and Mary Doubleday. Their combined expertise fosters a creative environment that enhances the potential for groundbreaking discoveries in their field.

Conclusion

Kyle Armbruster's contributions to the field of pharmaceuticals through his innovative patent on squalamine dilactate exemplify his commitment to advancing medical science. His work continues to inspire and pave the way for future innovations in therapeutic applications.